Product Information
QUDEXY XR 100 MG CAPSULE is a brand product labeled by Upsher-Smith Laboratories LLC, priced at $24.1030 per EA under NDC 00245107430. Its NADAC has been published 286 times since Jun 20, 2018.
FDA first approved this application on Mar 11, 2014. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/1
Manufacturer
Upsher-Smith Laboratories LLCNDC
00245107430
Classification
Brand
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
4/23/2025
Active Ingredients
TOPIRAMATEApproval Type
New Drug (NDA)
FDA Application
NDA205122FDA Approved
3/11/2014
TE Code
AB2
On Market Since
4/11/2014
Pharmacological Classes
Price Statistics
The NADAC for QUDEXY XR 100 MG CAPSULE has been published 286 times since Jun 20, 2018, and over the history we have for it it has risen 37.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $24.1030 per EA |
|---|---|
| All-time high | $24.2543 (Dec 11, 2024) |
| All-time low | $17.4942 (Jun 20, 2018) |
| 52-week high | $24.1030 |
| 52-week low | $24.1030 |
| Median price | $22.1941 |
| Average price | $21.6057 |
| Largest weekly change | +6.0% (Feb 3, 2021) |
| Weeks tracked | 286 |
| Tracking since | Jun 20, 2018 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
0.0%
3Y
+8.6%
5Y
+8.6%
All
+37.8%
Last surveyed Dec 31, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 78% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of QUDEXY XR 100 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for QUDEXY XR 100 MG CAPSULE, manufactured by Upsher-Smith Laboratories LLC, is $24.1030 per EA (NDC 00245107430), effective Dec 31, 2025.
How has the price of QUDEXY XR 100 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for QUDEXY XR 100 MG CAPSULE has risen 37.8%. It has been tracked across 286 weekly CMS publications since Jun 20, 2018.
What are the highest and lowest recorded NADAC prices for QUDEXY XR 100 MG CAPSULE?
Since Jun 20, 2018, the NADAC for QUDEXY XR 100 MG CAPSULE has ranged from a low of $17.4942 (Jun 20, 2018) to a high of $24.2543 (Dec 11, 2024), with a median of $22.1941 per EA.
Are there cheaper alternatives to QUDEXY XR 100 MG CAPSULE?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TOPIRAMATE ER 100 MG SPRINK CAP, is $5.3819 per EA — about 78% below QUDEXY XR 100 MG CAPSULE.
Who manufactures QUDEXY XR 100 MG CAPSULE?
QUDEXY XR 100 MG CAPSULE (NDC 00245107430) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a brand product.